Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 41 studies | 42% ± 14% | |
pericyte | 36 studies | 47% ± 20% | |
smooth muscle cell | 31 studies | 45% ± 19% | |
myofibroblast cell | 13 studies | 45% ± 13% | |
connective tissue cell | 9 studies | 38% ± 13% | |
oligodendrocyte precursor cell | 9 studies | 38% ± 13% | |
classical monocyte | 6 studies | 23% ± 4% | |
adventitial cell | 5 studies | 49% ± 7% | |
endothelial cell | 4 studies | 20% ± 3% | |
hepatic stellate cell | 3 studies | 41% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
uterus | 4 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 22263.80 | 245 / 245 | 100% | 56.66 | 501 / 502 |
breast | 98% | 14406.33 | 452 / 459 | 95% | 40.45 | 1059 / 1118 |
lung | 100% | 19011.64 | 577 / 578 | 93% | 24.82 | 1075 / 1155 |
stomach | 94% | 11438.22 | 339 / 359 | 90% | 26.30 | 257 / 286 |
intestine | 97% | 15304.13 | 939 / 966 | 83% | 22.46 | 437 / 527 |
esophagus | 87% | 13332.14 | 1264 / 1445 | 92% | 28.86 | 168 / 183 |
bladder | 100% | 24668.29 | 21 / 21 | 79% | 20.18 | 398 / 504 |
uterus | 99% | 21927.61 | 168 / 170 | 63% | 17.18 | 290 / 459 |
skin | 92% | 11045.09 | 1656 / 1809 | 57% | 10.04 | 268 / 472 |
adrenal gland | 86% | 5350.77 | 223 / 258 | 61% | 11.07 | 141 / 230 |
thymus | 95% | 11247.11 | 622 / 653 | 51% | 7.57 | 309 / 605 |
pancreas | 42% | 1686.11 | 139 / 328 | 97% | 84.04 | 172 / 178 |
ovary | 81% | 15952.07 | 145 / 180 | 51% | 12.47 | 218 / 430 |
kidney | 53% | 3973.67 | 47 / 89 | 70% | 19.34 | 634 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.22 | 1 / 1 |
adipose | 99% | 16193.35 | 1188 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 10696.93 | 1151 / 1335 | 0% | 0 | 0 / 0 |
spleen | 84% | 5313.01 | 203 / 241 | 0% | 0 | 0 / 0 |
heart | 75% | 4258.95 | 647 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 12.65 | 31 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 9.49 | 16 / 29 |
peripheral blood | 50% | 4471.13 | 467 / 929 | 0% | 0 | 0 / 0 |
liver | 13% | 476.88 | 29 / 226 | 32% | 5.91 | 131 / 406 |
brain | 4% | 126.12 | 93 / 2642 | 35% | 4.92 | 245 / 705 |
muscle | 25% | 978.75 | 203 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.18 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0030324 | Biological process | lung development |
GO_0060325 | Biological process | face morphogenesis |
GO_0005615 | Cellular component | extracellular space |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0030133 | Cellular component | transport vesicle |
GO_0008201 | Molecular function | heparin binding |
GO_0005539 | Molecular function | glycosaminoglycan binding |
Gene name | CRISPLD2 |
Protein name | Cysteine rich secretory protein LCCL domain containing 2 Cysteine-rich secretory protein LCCL domain-containing 2 (Cysteine-rich secretory protein 11) (CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2) |
Synonyms | UNQ2914/PRO1156/PRO9783 LCRISP2 CRISP11 |
Description | FUNCTION: Promotes matrix assembly. . |
Accessions | Q9H0B8 ENST00000566165.1 ENST00000564567.5 [Q9H0B8-2] ENST00000567845.5 ENST00000563066.5 J3QKP2 H3BS62 ENST00000566151.1 H3BTI0 ENST00000262424.10 [Q9H0B8-1] ENST00000566789.1 H3BSZ9 ENST00000569090.1 [Q9H0B8-5] H3BTP0 |